Callan Family Office LLC Invests $2.22 Million in Agilent Technologies, Inc. $A

Callan Family Office LLC bought a new position in Agilent Technologies, Inc. (NYSE:A - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 16,725 shares of the medical research company's stock, valued at approximately $2,222,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Brighton Jones LLC raised its stake in shares of Agilent Technologies by 6.1% during the fourth quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company's stock valued at $626,000 after acquiring an additional 270 shares during the last quarter. Jones Financial Companies Lllp increased its holdings in Agilent Technologies by 15.9% during the 1st quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company's stock valued at $602,000 after purchasing an additional 769 shares during the period. Geneos Wealth Management Inc. raised its position in Agilent Technologies by 54.8% during the 1st quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company's stock valued at $70,000 after purchasing an additional 212 shares during the last quarter. Acadian Asset Management LLC raised its position in Agilent Technologies by 16.5% during the 1st quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company's stock valued at $625,000 after purchasing an additional 758 shares during the last quarter. Finally, Sivia Capital Partners LLC purchased a new stake in Agilent Technologies in the 2nd quarter worth approximately $273,000.

Analyst Ratings Changes

A has been the topic of a number of recent analyst reports. Jefferies Financial Group started coverage on Agilent Technologies in a research report on Thursday, July 9th. They issued a "hold" rating and a $135.00 price objective on the stock. Piper Sandler assumed coverage on Agilent Technologies in a report on Thursday, June 11th. They set a "neutral" rating and a $150.00 target price for the company. TD Cowen raised their price target on Agilent Technologies from $147.00 to $155.00 and gave the stock a "buy" rating in a research note on Thursday, May 28th. Royal Bank Of Canada assumed coverage on shares of Agilent Technologies in a report on Wednesday, May 27th. They issued an "outperform" rating and a $153.00 price target on the stock. Finally, Wall Street Zen raised shares of Agilent Technologies from a "hold" rating to a "buy" rating in a research report on Sunday, August 2nd. Two research analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat, Agilent Technologies has a consensus rating of "Moderate Buy" and a consensus price target of $160.24.

Agilent Technologies Stock Performance

Agilent Technologies stock opened at $159.25 on Friday. Agilent Technologies, Inc. has a fifty-two week low of $108.35 and a fifty-two week high of $160.51. The stock's 50 day simple moving average is $137.57 and its two-hundred day simple moving average is $126.23. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10. The stock has a market cap of $44.98 billion, a price-to-earnings ratio of 31.98, a PEG ratio of 2.81 and a beta of 1.25.

Agilent Technologies (NYSE:A - Get Free Report) last announced its earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.41 by $0.08. The firm had revenue of $1.83 billion during the quarter, compared to analyst estimates of $1.80 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The business's revenue was up 10.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, analysts expect that Agilent Technologies, Inc. will post 6.05 earnings per share for the current fiscal year.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source